Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-01-26

FDA Approved: FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI — Supplemental Application (Dr. Reddy's Laboratories Inc.)

View source ↗

Summary

FDA approved a supplemental application for a fixed-dose combination of fexofenadine HCl and pseudoephedrine HCl to treat allergy symptoms with nasal congestion…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fexofenadine HCl and Pseudoephedrine HCl (Fexofenadine HCl and Pseudoephedrine HCl)

Snippet

SUPPL AP for FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI (FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI)